(Q52617228)
Statements
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors. (English)
Alison T Stopeck
Lucas Wong
Lee S Rosen
Philip E Thorpe
Joseph S Shan
Nuhad K Ibrahim
11 October 2011
17
21
6888-6896